Literature DB >> 19921518

Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA).

Karim Makdoumi1, Anders Bäckman, Jes Mortensen, Sven Crafoord.   

Abstract

BACKGROUND: To evaluate the antibacterial efficacy of photo-activated riboflavin using Ultraviolet A (UVA) on three bacterial strains commonly detected in keratitis.
METHODS: Three bacterial strains (Staphylococcus epidermidis, Staphylococcus aureus and Pseudomonas aeruginosa) were cultured on blood/hematin-agar plates and dispersed in PBS. Dispersion was done of 10 microl of bacterial stock-solutions in 90 microl of RPMI, where different riboflavin molarities had been added, to achieve a bacterial concentration of 1-4 x 10 (4)/ml. Riboflavin end molarities before illumination were 0, 100, 200, 300 and 400 microM. Each solution had a negative control. The solutions were illuminated with UVA (365 nm) for 30 minutes (5.4 J/cm(2)) and then continued for a total time of 60 minutes (10.8 J/cm(2)). A count of CFU was conducted after incubation and results compared.
RESULTS: In all tested strains, a slight decrease of bacteria was seen when exposed to UV for 30 minutes. A doubling of the UV dose showed a marked decrease of bacterial count in all bacteria tested. The combination of UV and riboflavin showed a more extensive reduction of CFU, confirming an interaction effect between UV and riboflavin.
CONCLUSION: Riboflavin photo-activation using UVA (365 nm) can achieve an extensive eradication of bacteria, and the combination is more potent in reducing bacterial number than UV alone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19921518     DOI: 10.1007/s00417-009-1231-2

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  35 in total

1.  Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.

Authors:  L J Cardo; F J Rentas; L Ketchum; J Salata; R Harman; W Melvin; P J Weina; J Mendez; H Reddy; R Goodrich
Journal:  Vox Sang       Date:  2006-02       Impact factor: 2.144

Review 2.  What is in the pipeline for Gram-negative pathogens?

Authors:  George H Talbot
Journal:  Expert Rev Anti Infect Ther       Date:  2008-02       Impact factor: 5.091

3.  Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results.

Authors:  Frederik Raiskup-Wolf; Anne Hoyer; Eberhard Spoerl; Lutz E Pillunat
Journal:  J Cataract Refract Surg       Date:  2008-05       Impact factor: 3.351

4.  Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.

Authors:  S Perez-Pujol; R Tonda; M Lozano; B Fuste; I Lopez-Vilchez; A M Galan; J Li; R Goodrich; G Escolar
Journal:  Transfusion       Date:  2005-06       Impact factor: 3.157

Review 5.  Crosslinking treatment of progressive keratoconus: new hope.

Authors:  Gregor Wollensak
Journal:  Curr Opin Ophthalmol       Date:  2006-08       Impact factor: 3.761

6.  [Irradiation of cornea with ultraviolet light and riboflavin administration as a new treatment for erosive corneal processes, preliminary results in four patients].

Authors:  E Schnitzler; E Spörl; T Seiler
Journal:  Klin Monbl Augenheilkd       Date:  2000-09       Impact factor: 0.700

7.  Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts.

Authors:  Hans Peter Iseli; Michael A Thiel; Farhad Hafezi; Juergen Kampmeier; Theo Seiler
Journal:  Cornea       Date:  2008-06       Impact factor: 2.651

8.  Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis.

Authors:  Majid Moshirfar; Jay J Meyer; Ladan Espandar
Journal:  J Cataract Refract Surg       Date:  2007-11       Impact factor: 3.351

9.  Contralateral eye study of corneal collagen cross-linking with riboflavin and UVA irradiation in patients with keratoconus.

Authors:  Efekan Coskunseven; Mirko R Jankov; Farhad Hafezi
Journal:  J Refract Surg       Date:  2009-04       Impact factor: 3.573

10.  Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis.

Authors:  Farhad Hafezi; John Kanellopoulos; Rainer Wiltfang; Theo Seiler
Journal:  J Cataract Refract Surg       Date:  2007-12       Impact factor: 3.351

View more
  24 in total

1.  Bactericidal effect of photo-activated riboflavin using UVA.

Authors:  Viroj Wiwanitkit
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-01-21       Impact factor: 3.117

2.  Dual-wavelength photo-killing of methicillin-resistant Staphylococcus aureus.

Authors:  Leon G Leanse; Xueping Sharon Goh; Ji-Xin Cheng; David C Hooper; Tianhong Dai
Journal:  JCI Insight       Date:  2020-06-04

3.  Different photodynamic effects of blue light with and without riboflavin on methicillin-resistant Staphylococcus aureus (MRSA) and human keratinocytes in vitro.

Authors:  Karim Makdoumi; Marie Hedin; Anders Bäckman
Journal:  Lasers Med Sci       Date:  2019-03-30       Impact factor: 3.161

Review 4.  Therapeutic and inducing effect of corneal crosslinking on infectious keratitis.

Authors:  Liang-Zhu Jiang; Shi-Yan Qiu; Zhi-Wei Li; Xiao Zhang; Xiang-Chen Tao; Guo-Ying Mu
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

5.  Bacteria repelling on highly-ordered alumina-nanopore structures.

Authors:  Sunghan Kim; Yan Zhou; Jeffrey D Cirillo; Andreas A Polycarpou; Hong Liang
Journal:  J Appl Phys       Date:  2015-04-16       Impact factor: 2.546

6.  Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts.

Authors:  Ricardo Lamy; Elliot Chan; Samuel D Good; Vicky Cevallos; Travis C Porco; Jay M Stewart
Journal:  Clin Exp Ophthalmol       Date:  2016-02-23       Impact factor: 4.207

7.  Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates.

Authors:  Alejandro Arboleda; Darlene Miller; Florence Cabot; Mukesh Taneja; Mariela C Aguilar; Karam Alawa; Guillermo Amescua; Sonia H Yoo; Jean-Marie Parel
Journal:  Am J Ophthalmol       Date:  2014-04-29       Impact factor: 5.258

Review 8.  New photosensitizers for photodynamic therapy.

Authors:  Heidi Abrahamse; Michael R Hamblin
Journal:  Biochem J       Date:  2016-02-15       Impact factor: 3.857

9.  Comparison of UVA- and UVA/riboflavin-induced growth inhibition of Acanthamoeba castellanii.

Authors:  Karim Makdoumi; Anders Bäckman; Jes Mortensen; Anders Magnuson; Sven Crafoord
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-19       Impact factor: 3.117

10.  Aspergillus flavus Keratitis: Experience of a Tertiary Eye Clinic in Turkey.

Authors:  Elif Erdem; Meltem Yagmur; Hazal Boral; Macit Ilkit; Reha Ersoz; Seyedmojtaba Seyedmousavi
Journal:  Mycopathologia       Date:  2016-11-08       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.